Selective activity of dasatinib for the most common KIT mutation in melanoma (L576P)
Woodman SE
•
Trent JC
•
Stemke Hale K
altro
Davies MA
2009
Periodico
JOURNAL OF CLINICAL ONCOLOGY
WOS
Archivio
Diritti
metadata only access
Soggetti